December 2022 PMID 36695469

Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022.

Yanis Merad, Alexandre Gaymard, Laurent Cotte, Thomas Perpoint, Dulce Alfaiate, Matthieu Godinot, Agathe Becker, Olivier Cannesson, Anne-Sophie Batalla, Fatima Oria-Yassir, Sophie Landré, Florence Morfin, Maude Bouscambert, Florent Valour, Florence Ader

Mentions

18
Peak: 15 in Dec 2022
across 4 sources since Dec 2022

Extended reach

293,181
potential audience

Total likes

232

Video views

14,685

Mentions per month

Dec 2022 – Aug 2024

Where it's discussed

  • X / Twitter14 posts
  • YouTube2 videos
  • Bluesky1 posts
  • Blogs1 articles

AI synopsis

What people are saying

The overall tone suggests a moderate interest and agreement with the study, as discussions mention key details like the 10% vaccine failure rate and the mild symptoms among breakthrough cases, often using straightforward language that indicates recognition of the study's relevance while not delving deeply into methodological critiques or broader implications.

AgreementModerate agreement

Most discussions acknowledge the findings, such as the 10% breakthrough infection rate and the observed mild symptoms, showing moderate support for the study's conclusions.

InterestModerate interest

The discussions reflect a moderate level of curiosity, focusing on vaccine effectiveness and implications for public health, but lack deep analysis or critique.

EngagementModerate engagement

Participants reference specific data points like the 10% failure rate and mention related institutions or ongoing discussions, indicating an engaged but not intensive level of interaction.

ImpactModerate impact

The conversation recognizes the importance of the findings for understanding vaccine outcomes and public health strategies, signifying a moderate perceived impact.

Abstract in brief

  • The Modified vaccinia virus Ankara (MVA-BN) vaccine is recommended for individuals who have been exposed to mpox within 14 days, but its effectiveness remains uncertain.
  • In a study of 108 adults who received the vaccine after exposure, 10% experienced breakthrough mpox infections.
  • Sexual contact was identified as a significant risk factor for these breakthrough cases, and vaccinated individuals had similar rates of infectious virus presence compared to unvaccinated cases.

Top posts

Most liked on X and Bluesky
Helen Branswell
@HelenBranswell · X

A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Boghuma https://t.co/5BeULCs003

Dec 15, 2022 · 11 likes · 5 shares · 207,202 followers View post →
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X

mpoxに対してMVA-BNを用いた曝露後予防接種では108人が曝露後14日以内に1回接種し、10%がブレイクスルー感染が生じた 性的接触による曝露がブレイクスルーに関連 Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox https://t.co/WsKsUHBm2Z https://t.co/5OOlrguCRG https://t.co/5ZhMn7BEZc

Dec 21, 2022 · 6 likes · 12,355 followers View post →
Eurosurveillance
@Eurosurveillanc · X

@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022

Dec 18, 2022 · 2 likes · 1 share · 16,590 followers View post →
Eurosurveillance
@Eurosurveillanc · X

@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU @Y_Merad @DulceAlfaiate Of 108 adults who received one dose of MVA-BN after exposure to #mpox

Dec 21, 2022 · 1 like · 1 share · 16,590 followers View post →
EUPHA-IDC section
@EuphaIdc · X

Eurosurveillanc: RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Bog… https://t.co/RvkqOytn0e

Dec 15, 2022 · 1 like · 854 followers View post →
EUPHA-IDC section
@EuphaIdc · X

Eurosurveillanc: @rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 … https://t.co/tDu1kZWdTR

Dec 18, 2022 · 1 like · 854 followers View post →

All mentions

Phage Papers
@Phage_Papers · X

Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 https://t.co/VKuCvjOOuB

Jan 25, 2023 · 646 followers View post →
Mugen UJIIE (氏家 無限)
@carpe_diem0820 · X

mpoxに対してMVA-BNを用いた曝露後予防接種では108人が曝露後14日以内に1回接種し、10%がブレイクスルー感染が生じた 性的接触による曝露がブレイクスルーに関連 Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox https://t.co/WsKsUHBm2Z https://t.co/5OOlrguCRG https://t.co/5ZhMn7BEZc

Dec 21, 2022 · 6 likes · 12,355 followers View post →
Eurosurveillance
@Eurosurveillanc · X

@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU @Y_Merad @DulceAlfaiate Of 108 adults who received one dose of MVA-BN after exposure to #mpox

Dec 21, 2022 · 1 like · 1 share · 16,590 followers View post →
HAS-veille
@HAS_veille · X

Eurosurveillance | Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 https://t.co/NWvHj02HpX

Dec 19, 2022 · 4,135 followers View post →
Simon Pollett
@simon_pollett · X

RT @Eurosurveillanc: @rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication Outcomes of post-exposure vaccination by modified vaccinia A…

Dec 18, 2022 · 1 share · 254 followers View post →
EUPHA-IDC section
@EuphaIdc · X

Eurosurveillanc: @rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022 … https://t.co/tDu1kZWdTR

Dec 18, 2022 · 1 like · 854 followers View post →
Eurosurveillance
@Eurosurveillanc · X

@rivm @rki_de @ECDC_HIVAIDS @ECDC_EU Rapid communication Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent #Mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022

Dec 18, 2022 · 2 likes · 1 share · 16,590 followers View post →
V.
@drmom01 · X

RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…

Dec 16, 2022 · 5 shares · 473 followers View post →
MaryAnn Decker
@MaryAnn27608053 · X

RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…

Dec 16, 2022 · 5 shares · 365 followers View post →
Donal BIsanzio
@donal_bisanzio · X

RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…

Dec 15, 2022 · 5 shares · 1,380 followers View post →
D'Ombre et de Lumière
@louvetou · X

RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…

Dec 15, 2022 · 5 shares · 133 followers View post →
EUPHA-IDC section
@EuphaIdc · X

Eurosurveillanc: RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Bog… https://t.co/RvkqOytn0e

Dec 15, 2022 · 1 like · 854 followers View post →
Daniel Mucida
@danmucida.bsky.social · Bluesky

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.50.2200882?emailalert=true https://scicomm.xyz/@HelenBranswell/109518672689753619 (2/2)

Dec 15, 2022 View post →
Eurosurveillance
@Eurosurveillanc · X

RT @HelenBranswell: A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exp…

Dec 15, 2022 · 5 shares · 16,590 followers View post →
Helen Branswell
@HelenBranswell · X

A small study in France showed a 10% vaccine failure rate in people who got a single dose of #mpox vaccine after an exposure event. People who developed the infection had mild symptoms. In @Eurosurveillanc. Attn @Boghuma https://t.co/5BeULCs003

Dec 15, 2022 · 11 likes · 5 shares · 207,202 followers View post →
Study examines Mpox prevention with modified vaccinia Ankara (MVA)
Blogs

https://doi.org/10.2807/1560-7917.ES.2022.27.50.2200882, https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2022.27.50.2200882. Be ...

Dec 18, 2022 View →